We found that BACH2 is a target gene of miR-130-3p and that the overexpression of miR-130-3p attenuates the promotion effect of BACH2 on NPC cell proliferation, migration, invasion, and anti-apoptosis. This evidence concerns the gene BACH2 and nasopharyngeal carcinoma.